1. Home
  2. HALO vs CRDO Comparison

HALO vs CRDO Comparison

Compare HALO & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CRDO
  • Stock Information
  • Founded
  • HALO 1998
  • CRDO 2008
  • Country
  • HALO United States
  • CRDO Cayman Islands
  • Employees
  • HALO N/A
  • CRDO N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CRDO Semiconductors
  • Sector
  • HALO Health Care
  • CRDO Technology
  • Exchange
  • HALO Nasdaq
  • CRDO Nasdaq
  • Market Cap
  • HALO 7.6B
  • CRDO 18.9B
  • IPO Year
  • HALO N/A
  • CRDO 2022
  • Fundamental
  • Price
  • HALO $76.68
  • CRDO $172.31
  • Analyst Decision
  • HALO Buy
  • CRDO Strong Buy
  • Analyst Count
  • HALO 8
  • CRDO 12
  • Target Price
  • HALO $70.25
  • CRDO $129.91
  • AVG Volume (30 Days)
  • HALO 1.8M
  • CRDO 5.4M
  • Earning Date
  • HALO 10-30-2025
  • CRDO 09-03-2025
  • Dividend Yield
  • HALO N/A
  • CRDO N/A
  • EPS Growth
  • HALO 68.93
  • CRDO N/A
  • EPS
  • HALO 4.37
  • CRDO 0.67
  • Revenue
  • HALO $1,178,672,000.00
  • CRDO $600,135,000.00
  • Revenue This Year
  • HALO $32.57
  • CRDO $125.11
  • Revenue Next Year
  • HALO $23.25
  • CRDO $26.83
  • P/E Ratio
  • HALO $17.55
  • CRDO $256.06
  • Revenue Growth
  • HALO 34.97
  • CRDO 175.81
  • 52 Week Low
  • HALO $42.01
  • CRDO $27.03
  • 52 Week High
  • HALO $77.60
  • CRDO $176.70
  • Technical
  • Relative Strength Index (RSI)
  • HALO 72.91
  • CRDO 79.00
  • Support Level
  • HALO $75.19
  • CRDO $157.77
  • Resistance Level
  • HALO $77.60
  • CRDO $168.14
  • Average True Range (ATR)
  • HALO 1.75
  • CRDO 7.70
  • MACD
  • HALO -0.37
  • CRDO 2.52
  • Stochastic Oscillator
  • HALO 84.92
  • CRDO 92.75

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

Share on Social Networks: